Damn, that is a tough chart to get a handle on. It has crossed over my 20, 50 and 200 day moving averages and went above the bollinger upper band on 11/2 where the HOD was .0042. the bollinger bands are headed up and the upper band is now sitting at .0043 whereas today's close and High Of Day is .0041. On October 17th, the slow stochastic dropped below the oversold mark of 80.00 From that date, the signal continued downward until October 31st when it began heading up. Yesterday the signal closed at 71.43. Today the slow stochastic closed at 67.35, as it turned downward.

The RSI on the other hand is turned upward at 61.06. Now, the MacD is in positive territory but running parallel with the 0.003.

I have to tell you that although the signals are screwy, the chart is headed in a positive direction (all in my own opinion) and I would wait for an hour after opening to make sure of the positive direction I am seeing from the Bollinger Bands.

Let me check with how the tests are coming along to present to the FDA. I know the study in Australia show good results but I want to see what date is reserved for any FDA review of the company's Phase 1b/2 study. It does appear from the write-up that they might have been approved to move into a further stage study based on good Stage1 results. One other thing I look at with these Bio-Pharms is how the stock is ticking the closer to reviews. Depending on the date for the review, sometimes some insiders tell a relative or 4 and you can see some buying or selling going on. I will see if I can get a date.